证券代码：830832 证券简称：齐鲁华信 公告编号：2023-022 山东齐鲁华信实业股份有限公司 稳定股价措施实施结果公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 本次增持计划具体内容详见本公司于 2023 年 5 月 19 日披露的《山东齐鲁华 信实业股份有限公司关于实施稳定股价方案的公告》（公告编号：2023-020）。 （三） 增持措施实施结果 2023 年 5 月 19 日，山东齐鲁华信实业股份有限公司（以下简称"公司"） 发布了《山东齐鲁华信实业股份有限公司关于实施稳定股价方案的公告》。 一、 股份增持情况 为维护公司上市后股价的稳定，保护投资者的利益，增持主体遵循《北京证 券交易所上市规则（试行）》等相关法律法规，于 2023 年 5 月 22 日至 2023 年 7 月 4 日期间内实施稳定股价增持方案，自二级市场竞价买入共计 57,320 股，实 际增持总金额为 269,926.33 元。 | 股东名称 | 股东身份 | 增持计划实施前 | 增持计划实施前持 | | --- ...

北京市通商律师事务所 关于山东齐鲁华信实业股份有限公司 2022 年年度股东大会 法律意见书 二〇二三年五月 中国北京建国门外大街 1 号国贸写字楼 2 座 12-14 层 100004 12-14th Floor, China World Office 2, No. 1 Jianguomenwai Avenue, Beijing 100004, China 电话 Tel: +86 10 6563 7181 传真 Fax: +86 10 6569 3838 电邮 Email: beijing@tongshang.com 网址 Web: www.tongshang.com 关于山东齐鲁华信实业股份有限公司 2022 年年度股东大会法律意见书 致：山东齐鲁华信实业股份有限公司 北京市通商律师事务所（以下简称"本所"）接受山东齐鲁华信实业股份有 限公司（以下简称"公司"）的委托，委派本所律师出席了公司 2022 年年度股 东大会（"本次股东大会"），并根据《中华人民共和国公司法》（以下简称"《公 司法》"）、《山东齐鲁华信实业股份有限公司公司章程》（以下简称"《公司 章程》"）及《山东齐鲁华信实业股份有限公司股东大 ...

证券代码：830832 证券简称：齐鲁华信 公告编号：2023-021 山东齐鲁华信实业股份有限公司 2022 年年度股东大会决议公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、会议召开和出席情况 （一）会议召开情况 1.会议召开时间：2023 年 5 月 26 日 2.会议召开地点：山东省淄博市周村区体育场路 1 号华信大厦二楼会议室 3.会议召开方式：本次会议采用现场投票和网络投票相结合方式召开 4.会议召集人：董事会 5.会议主持人：明曰信 6.召开情况合法、合规、合章程性说明： 本次股东大会的召集及召开时间、方式、召集人及主持人符合《中华人民共 和国公司法》《山东齐鲁华信实业股份有限公司章程》及《山东齐鲁华信实业股 份有限公司股东大会议事规则》等有关规定，无需其他相关部门批准或履行其他 程序。 （二）会议出席情况 出席和授权出席本次股东大会的股东共 105 人，持有表决权的股份总数 30,029,905 股，占公司有表决权股份总数的 21.69%。 其中通过网络投票参与本次股东大会的股 ...

关于实施稳定股价方案的公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 为维护山东齐鲁华信实业股份有限公司（以下简称"公司"）上市后股价的 稳定，保护投资者的利益，公司制定了稳定股价预案，该预案已经本公司第三届 董事会第十七次会议和 2020 年第三次临时股东大会审议通过。 一、 稳定股价措施的触发条件 （一）稳定股价预案的启动条件 公司自上市（精选层挂牌）之日起第 4 个月至三年内非因不可抗力因素所致， 如公司股票收盘价格连续 20 个交易日均低于最近一期经审计的每股净资产（最 近一期审计基准日后，因利润分配、资本公积金转增股本、增发、配股等情况导 致公司净资产或股份总数出现变化的，每股净资产相应进行调整）（以下简称"启 动条件"）且同时满足监管机构对于增持或回购公司之股份等行为的规定，公司 及相关主体应按预案启动以下稳定股价措施。 证券代码：830832 证券简称：齐鲁华信 公告编号：2023-020 山东齐鲁华信实业股份有限公司 （二）触发启动条件的具体情形 公司于 2021 年 2 月 23 ...

一、 稳定股价措施的启动条件 证券代码：830832 证券简称：齐鲁华信 公告编号：2023-019 山东齐鲁华信实业股份有限公司 触发稳定股价措施启动条件的提示性公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 为维护山东齐鲁华信实业股份有限公司（以下简称"公司"）上市后股价的 稳定，保护投资者的利益，公司制定了稳定股价预案。该预案已分别经本公司第 三届董事会第十七次会议以及 2020 年第三次临时股东大会审议通过，并已在公 开发行说明书中披露。 2023 年 5 月 19 日 公司自上市（精选层挂牌）之日起第 4 个月至三年内非因不可抗力因素所致， 如公司股票收盘价格连续 20 个交易日均低于最近一期经审计的每股净资产（最 近一期审计基准日后，因利润分配、资本公积金转增股本、增发、配股等情况导 致公司净资产或股份总数出现变化的，每股净资产相应进行调整）且同时满足监 管机构对于增持或回购公司之股份等行为的规定，公司及相关主体应按本预案启 动稳定股价措施。 二、 触发启动条件的具体情形 公司于 20 ...

□特定对象调研 业绩说明会 □媒体采访 □现场参观 证券代码：830832 证券简称：齐鲁华信 公告编号：2023-018 山东齐鲁华信实业股份有限公司 投资者关系活动记录表 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、投资者关系活动类别 □新闻发布会 □分析师会议 □路演活动 □其他（请文字说明其他活动内容） 二、投资者关系活动情况 （一）活动时间、地点 山东齐鲁华信实业股份有限公司(以下简称"公司")于 2023 年 5 月 10 日（周 三）15:00-17:00 在全景网"投资者关系互动平台"（https://ir.p5w.net）举 行 2022 年年度报告业绩说明会，并与投资者进行了沟通交流，本次年度报告业 绩说明会采用网络远程的方式举行。 （二）参与单位及人员 通过网络方式参加公司 2022 年年度报告业绩说明会的投资者。 （三）上市公司接待人员 1 问题 3、请问总经理，公司 4 月下旬股价低于每股净资产 5.5 元，如果连续 20 个交易日股价破净，是否会再次触发稳定股价措施？ ...

证券代码：830832 证券简称：齐鲁华信 公告编号：2023-017 山东齐鲁华信实业股份有限公司 2022 年年度报告说明会预告公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 三、 参加人员 一、 说明会类型 山东齐鲁华信实业股份有限公司（以下简称"公司"）于 2023 年 4 月 25 日 在北京证券交易所指定信息披露平台（www.bse.cn）披露了《山东齐鲁华信实业 股份有限公司 2022 年年度报告》（公告编号：2023-006），为方便广大投资者进 一步了解公司 2022 年年度经营业绩情况，公司拟召开 2022 年年度报告业绩说明 会。 二、 说明会召开的时间、地点 （一）会议召开时间：2023 年 5 月 10 日 15:00-17:00。 （二）会议召开地点 本次年度报告业绩说明会将采用网络方式召开，投资者可登录全景网"投资 者关系互动平台"（http//ir.p5w.net）参与本次年度报告业绩说明会。 董事长：明曰信先生 董事、总经理：李晨光先生 董事、副总经理：明伟先生 ...

Financial Performance - In 2022, the company achieved operating revenue of 577.23 million, a slight decrease from 579.67 million in 2021, and 555.56 million in 2020[13]. - The company's operating revenue for 2022 was CNY 577,228,216.28, a decrease of 0.42% compared to CNY 579,665,590.80 in 2021[34]. - The net profit attributable to shareholders for 2022 was CNY 46,877,946.19, down 22.70% from CNY 60,640,445.07 in 2021[34]. - The gross profit margin decreased to 19.01% in 2022 from 25.71% in 2021[34]. - The company's cash flow from operating activities decreased by 49.08% to CNY 26,965,386.96 in 2022[38]. - The basic earnings per share fell to 0.34 in 2022, a decline of 26.06% from 0.46 in 2021[34]. - The company's debt-to-asset ratio increased to 27.98% in 2022 from 24.64% in 2021[36]. - The company's total assets increased by 9.11% to CNY 1,060,552,556.67 in 2022, compared to CNY 972,018,824.47 in 2021[36]. - Total liabilities rose by 23.93% to CNY 296,768,103.53 in 2022 from CNY 239,472,523.53 in 2021[36]. Client Dependency - The company's first major client, China Petroleum & Chemical Corporation, accounted for 34.49% of sales in 2022, up from 30.42% in 2021 and 28.48% in 2020[13]. - The company has a high dependency on the petrochemical industry, with sales to petrochemical clients accounting for 62.90% of total revenue in 2022[14]. - Major customers accounted for 88.86% of total sales, with the largest customer contributing ¥221,864,186.91, representing 38.44% of total sales[79]. - The company is facing risks from concentrated customer reliance, with over 38% of sales dependent on Sinopec and its subsidiaries[123]. Research and Development - The company increased its patent portfolio by 18 new patents in 2022, including 12 invention patents, bringing the total to 60 patents, with 30 being invention patents[7]. - The company has obtained a total of 60 patents as of December 31, 2022, including 30 invention patents, indicating a strong focus on R&D[15]. - The company has completed several R&D projects, including the recycling of aluminum-containing waste, which is expected to significantly improve cost efficiency and environmental impact[98]. - The company is actively engaged in developing new technologies, including low-turbidity aluminum sulfate production processes, which are expected to enhance product quality and market competitiveness[98]. - The company emphasizes the importance of R&D and innovation, actively seeking collaborations with domestic research institutions and well-known enterprises to enhance its technological capabilities[131]. Market Trends and Risks - The demand for core molecular sieve products in the petrochemical sector has shown signs of decline, influenced by market competition and the shift towards electric vehicles[52]. - The market for adsorbent products is rapidly growing, particularly in medical and industrial applications for oxygen and hydrogen production[119]. - The global demand for refining catalysts is projected to increase at an annual rate of 3.6%, reaching a consumption value of $4.7 billion by 2020[57]. - The implementation of the National VI emission standards is expected to create a surge in demand for molecular sieve products used in diesel vehicle exhaust treatment[59]. - The company is subject to environmental protection risks, which may increase operational costs due to stricter regulations in the future[14]. Financial Management and Investments - The company has provided guarantees totaling CNY 75 million, with a remaining balance of CNY 30.02 million, indicating significant financial commitments[139]. - The company has a loan of CNY 19.75 million from Shandong Zhou Village Bank with an interest rate of 5.50%[185]. - The company has secured a credit loan of 19,600,000.00 with a 4.50% interest rate, maturing in February 2024[186]. - The company plans to distribute a cash dividend of 0.60 yuan for every 10 shares, with the distribution date set for July 13, 2022[194]. - The company has not proposed any cash dividend distribution plan despite having positive undistributed profits during the reporting period[195]. Strategic Changes and Future Plans - The company plans to change the use of raised funds from a 2000-ton automotive exhaust treatment material production line to include a new 3000-ton adsorbent material production line, which is part of a major project in Shandong Province[7]. - The company plans to focus on new product development and market expansion in 2023, aiming for high-quality growth and improved digital management[120]. - The company is shifting its business focus towards new materials for environmental protection and adsorbents, with plans to further develop oxygen and hydrogen adsorption materials[15]. - The company has established a new production line for adsorbent new materials with a capacity of 3,000 tons, which is included in the 2022 Shandong Province major implementation projects[131]. Corporate Governance and Shareholding - The company has a relatively dispersed shareholding structure, with the largest shareholder holding 9.05% of the shares, leading to potential control risks[16]. - The actual controller's shareholding is relatively dispersed, with the largest shareholder holding 9.05% of the shares, which poses a risk of control changes post-public offering[132]. - The company has a total of 8 actual controllers, with 5 of them serving as non-independent directors[198]. - The board of directors consists of 9 members, while the supervisory board has 3 members and there are 5 senior management personnel[197]. Environmental and Social Responsibility - The company is committed to social responsibility, emphasizing innovation and environmental protection in its operations[111]. - The company has implemented strategies to reduce environmental impact, including the development of processes to lower COD in molecular sieve filtrate, aligning with stricter domestic environmental regulations[99]. - The company donated a total of 402,800 yuan for poverty alleviation and charity during the reporting period[110].

招商证券股份有限公司 关于山东齐鲁华信实业股份有限公司 2022 年度募集资金存放与使用情况的专项核查报告 招商证券股份有限公司（以下简称"招商证券"或"保荐机构"）作为山东 齐鲁华信实业股份有限公司（以下简称"齐鲁华信"或"公司"）的保荐机构， 根据《证券发行上市保荐业务管理办法》《北京证券交易所股票上市规则（试行）》 《北京证券交易所证券发行上市保荐业务管理细则》等相关法律、法规和规范性 文件的规定，对齐鲁华信 2022 年度募集资金存放与使用情况进行了核查，具体 核查情况如下： 一、募集资金基本情况 经中国证券监督管理委员会《关于核准山东齐鲁华信实业股份有限公司向不 特定合格投资者公开发行股票的批复》（证监许可[2021]183 号）核准，公司发行 人民币普通股 38,390,345 股（超额配售选择权行使后），发行价格为人民币 7.00 元/股，募集资金总额为人民币 268,732,415.00 元（超额配售选择权行使后），扣 除发行费用人民币30,996,066.60元后，募集资金净额为人民币237,736,348.40元。 此次发行初始募集资金与超额配售部分募集资金分别于 2021 年 2 月 4 ...

Financial Performance - Operating revenue for Q1 2023 was CNY 108,553,565.66, down 34.20% from CNY 164,976,203.10 in Q1 2022[10] - Net profit attributable to shareholders for Q1 2023 was CNY 1,512,294.75, a decline of 87.05% compared to CNY 11,675,274.18 in the same period last year[10] - The net cash flow from operating activities was negative CNY 20,566,224.69, a decrease of 606.63% compared to CNY 4,059,428.74 in Q1 2022[10] - Total operating revenue for Q1 2023 was CNY 108,553,565.66, a decrease from CNY 164,976,203.10 in Q1 2022, representing a decline of approximately 34%[41] - Total operating costs for Q1 2023 were CNY 106,426,639.95, down from CNY 149,910,010.49 in Q1 2022, indicating a reduction of about 29%[41] - Net profit for Q1 2023 was CNY 1,512,294.75, significantly lower than CNY 11,675,274.18 in Q1 2022, reflecting a decrease of approximately 87%[42] - The company reported a net cash outflow from operating activities of CNY -20,566,224.69 in Q1 2023, compared to a net inflow of CNY 4,059,428.74 in Q1 2022[47] - The total comprehensive income for Q1 2023 was CNY 143,810.23, significantly lower than CNY 2,742,593.49 in Q1 2022[46] Assets and Liabilities - Total assets as of March 31, 2023, were CNY 1,057,217,872.45, a decrease of 0.31% compared to the end of 2022[10] - The company's asset-liability ratio (consolidated) was 27.58%, down from 27.98% at the end of 2022[10] - The company's current assets totaled CNY 634,297,031.70, down from CNY 639,223,426.75 in the previous period[33] - The company's total liabilities decreased from CNY 238,486,030.66 to CNY 218,692,069.38 in current liabilities[34] - Total liabilities as of March 31, 2023, were CNY 137,419,243.81, down from CNY 143,919,521.22 at the end of 2022, showing a reduction of about 4%[39] - The company's fixed assets decreased from CNY 242,594,971.72 to CNY 236,155,667.35[34] - The company's non-current assets totaled CNY 422,920,840.75, slightly up from CNY 421,329,129.92[34] Shareholder Information - The total number of ordinary shares outstanding is 138,763,865, with 89.98% being freely tradable shares[20] - The largest shareholder, Mingyue Xin, holds 12,560,110 shares, representing 9.05% of total shares[21] - The company has a total of 6,484 ordinary shareholders[20] - The core employees' shareholding decreased by 184,326 shares, resulting in a total of 7,066,553 shares, or 5.09%[20] - The total number of restricted shares is 13,910,261, accounting for 10.02% of total shares[20] - The second-largest shareholder, Shandong Xinghua, holds 5,803,200 shares, which is 4.18% of total shares[21] - The top ten shareholders collectively hold 38,387,866 shares, which is 27.66% of total shares[23] - The company does not have any preferred stock outstanding[24] - The largest shareholder's unrestricted shares amount to 9,420,083, while restricted shares total 3,140,027[23] - The total number of shares held by the third-largest shareholder, Ma Ning, is 3,581,511, representing 2.58%[22] Cash Flow and Expenses - Cash received from sales of goods and services was CNY 73,668,872.00, down 36.93% from CNY 116,799,685.26 in the same period last year[15] - Cash and cash equivalents decreased to CNY 24,224,242.67 as of March 31, 2023, from CNY 32,561,952.04 at the end of 2022, a decline of approximately 26%[37] - Cash and cash equivalents at the end of Q1 2023 were CNY 204,179,827.90, down from CNY 268,535,490.08 at the end of Q1 2022[48] - Cash inflow from financing activities was CNY 15,000,000.00, a decrease of 49.3% compared to CNY 29,600,000.00 in Q1 2022[50] - Cash paid for purchasing goods and services was CNY 17,334,305.65, an increase from CNY 16,486,399.16 in Q1 2022[50] - Cash paid to employees decreased to CNY 14,770,889.76 from CNY 16,270,636.79 in the same quarter last year[50] - Cash paid for taxes increased significantly to CNY 6,206,842.01 from CNY 2,587,624.18 in Q1 2022[50] Research and Development - Research and development expenses for Q1 2023 were CNY 4,047,607.87, compared to CNY 4,625,539.28 in Q1 2022, showing a decrease of approximately 12%[42] - Research and development expenses for Q1 2023 were CNY 2,071,221.62, a decrease of 12.2% from CNY 2,359,762.26 in Q1 2022[45]